Meta-analysis of CYP2C19 and CYP2D6 metabolic activity on antidepressant response from 13 clinical studies using genotype imputation is a research paper published in medRxiv (2023). On theSindex it has a DataRank of 0.165. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.165
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 2U19GM061388-11
Pharmacogenetics of Phase II Drug Metabolizing Enzymes
National Institutes of Health
Grant: 5U01MH109532-04
7/7 Psychiatric Genomics Consortium: Finding actionable variation
UK Research and Innovation
Grant: G0701420
A Genome Wide Association study of Unipolar Depression
National Institutes of Health
Grant: 3U01MH109528-02S1
1/7 Psychiatric Genomics Consortium: Finding actionable variation
Wellcome Trust
Grant: 226770
Understanding the causal mechanisms of antidepressant exposure and response
NIGMS NIH HHS
Grant: U19 GM061388
NIMH NIH HHS
Grant: R01 MH124873
NIMH NIH HHS
Grant: U01 MH109532
NIMH NIH HHS
Grant: U01 MH109528
Wellcome Trust
Fields of Study
Keywords
Sustainable Development Goals